Method of using bifidobacterium longum to treat depressive symptoms
Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; “empty” feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof. These depressive symptoms can be associated with a depressive state or depressive disorder or can be found sub-clinically or not associated with these depressive states/disorders (e.g., not part of a syndrome or psychiatric disorder).
1. A method of supplementing a regimen for treatment of a depressive symptom, the regimen comprises administering to an individual in need thereof a synthetic pharmaceutical compound, and comprising administering an edible composition comprising a therapeutically effective amount or a prophylactically effective amount of Bifidobacterium longum ATCC BAA-999 to the individual, wherein the depressive symptom is a secondary condition caused by an underlying medical condition selected from the group consisting of an endocrine disease, a cardiovascular disease, a pulmonary disease, a cancer, an autoimmune disease and combinations thereof, and wherein the combination of the synthetic pharmaceutical compound and the edible composition treats the depressive symptom.
2. The method of claim 1 , wherein the underlying medical condition is selected from the group consisting of a thyroid abnormality, a heart attack, a chronic obstructive pulmonary disease and rheumatoid arthritis.